Preclinical, Translational and Clinical-Stage Laboratories
Who We Are
MD Biosciences is a global industry-leading provider of preclinical, translational and clinical-phase contract research services for the development of pharmaceutical and diagnostic assets. With AAALAC-accredited, GLP-compliant, CLIA facilities, we offer expertise, services and products across a wide range of therapeutic areas including inflammatory diseases, autoimmunity, neurology, oncology, metabolism and pain.
What We Do
Preclinical services include efficacy and mode of action studies in the inflammation, immuno-oncology and CNS therapeutics areas. Translational services featuring porcine models and full-service histology/IHC/ISH capabilities bridge the gap between discovery-stage research findings and potential clinical utility, accelerating programs towards their next objectives and milestones. Clinical stage services are focused on biomarker validation laboratory testing and CDx development on multiple platforms, including flow cytometry, multiplexed IHC, proteomics and PCR.
Our CRO relationship model allows for transparent sharing of information, coordinated decision-making and a high level of flexibility. We approach each project uniquely as a team-oriented research effort. We host frequent discussions with our Sponsors to determine ultimate study objectives, adapt to new information as it is generated, and provide insight wherever possible.
"MD Biosciences, providing elegant solutions with expert execution for over 25 years"
Contact us today to learn more or discuss a study with one of our scientists!
North America (MN) and Massachusetts
3510 Hopkins Place North
Oakdale, MN 55128
Tel: (651) 641 1770
Toll Free: 888-876-3246
Fax: (651) 641 1773
Cambridge Office: 617 764 6555 Fax: (651) 641 1773 Email
MD Biosciences Innovalora Ltd
Weizmann Science Park
3 Sapir Street
Nes Ziona, Israel
Tel: +972 (8) 939 6884
MD Biosciences GmbH
8132 Egg b. Zürich Switzerland
Tel: +41-44 986 2628
Fax: +41-44 986 2630